LPAR1, lysophosphatidic acid receptor 1, 1902

N. diseases: 145; N. variants: 11
Disease: Endometrial Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.030 Biomarker disease BEFREE The immunohistochemical results revealed higher protein expression levels of ATX and LPA receptors (LPA 1, 2 and 3) in human endometrial cancer tissue than in non‑carcinoma tissue. 29328374 2018
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.030 Biomarker disease BEFREE Also, owing to the highest expression of LPARs, CYP19A1 and SRD5A2 as well as their association with depth of myoinvasion and FIGO stage LPAR2 and LPAR1 seem to be the efficient candidate prognostic markers in the individual, targeted therapies for EC. 29182028 2018
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.030 AlteredExpression disease BEFREE The studied ECs showed the highest LPAR2 and LPAR1 expression. 26327335 2015